Skip to content

CDR

KKR to sell remaining stake in WBA

KKR to sell remaining stake in WBA

Affiliates of private equity firm Kohlberg Kravis Roberts & Co. (KKR) plan to sell their remaining interest in Walgreens Boots Alliance (WBA) through a secondary stock offering. WBA said Wednesday that the KKR affiliates aim to sell 20.

Genoa pharmacist relishes clinical practice setting

Genoa pharmacist relishes clinical practice setting

Terica Gatewood left a retail pharmacy to work at Genoa, a QoL Healthcare Company, because she wanted a more clinical setting. At the Genoa pharmacy here, inside Valeo Behavioral Health, she has found that environment and then some.

Gillette launches Star Wars Rogue One gift packs

Gillette launches Star Wars Rogue One gift packs

Gillette has released special edition gift packs of men’s shaving products as part of its global campaign with Lucasfilm’s upcoming movie “Rogue One: A Star Wars Story.” The four gift packs, announced Tuesday, come in three product combinations with packaging that sports images from the film.

Camber ships generic of Crestor

Camber ships generic of Crestor

Camber Pharmaceuticals has released rosuvastatin tablets, a cholesterol-lowering medication. Camber said Monday that its product, a generic version of Crestor tablets from AstraZeneca Pharmaceuticals, comes in strengths of 5 mg, 10 mg, 20 mg and 40 mg.

Dietary supplement registry edges closer to launch

Dietary supplement registry edges closer to launch

WASHINGTON – The Supplement Online Wellness Library (OWL), being developed by Council for Responsible Nutrition (CRN) and independent safety science firm UL, has begun accepting product labels from dietary supplement manufacturers and marketers.

Physicians exhibit knowledge gap with biosimilars

Physicians exhibit knowledge gap with biosimilars

Though the vast majority of specialty physicians know what biosimilars are, their knowledge about these emerging medications falls short, according to a survey by the Biosimilars Forum. Of 1,201 U.S. physicians polled, 76.

Mylan releases generics of Benicar, Benicar HCT

Mylan releases generics of Benicar, Benicar HCT

Mylan N.V. has announced the U.S. launch of olmesartan medoxomil tablets and olmesartan medoxomil/hydrochlorothiazide tablets, two medications for high blood pressure. Mylan said the products mark the first generic versions of Benicar and Benicar HCT tablets from Daiichi Sankyo.

Don’t overlook biotherapeutics opportunity

Don’t overlook biotherapeutics opportunity

As a class, biotherapeutic agents are far too significant a chain pharmacy service and business opportunity to ignore. Over recent years biotherapeutic treatments have become significant, both as therapeutic options and as business opportunities.